Chrysotoxine structure
|
Common Name | Chrysotoxine | ||
|---|---|---|---|---|
| CAS Number | 156951-82-5 | Molecular Weight | 318.36 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C18H22O5 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of ChrysotoxineChrysotoxine is a dual inhibitor of Src/Akt. Chrysotoxine suppresses cancer stem cells (CSCs) phenotypes by down-regulating Src/Akt signaling. Chrysotoxine reduces cell viability and increases apoptosis level in H460 and H23 cells instead of non-tumor cell lines. Chrysotoxine shows rapid excretion and low bioavailability in rats. Chrysotoxine is used in cancer research[1][2]. |
| Name | 4-[2-(3,4-dimethoxyphenyl)ethyl]-2,6-dimethoxyphenol |
|---|---|
| Synonym | More Synonyms |
| Description | Chrysotoxine is a dual inhibitor of Src/Akt. Chrysotoxine suppresses cancer stem cells (CSCs) phenotypes by down-regulating Src/Akt signaling. Chrysotoxine reduces cell viability and increases apoptosis level in H460 and H23 cells instead of non-tumor cell lines. Chrysotoxine shows rapid excretion and low bioavailability in rats. Chrysotoxine is used in cancer research[1][2]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C18H22O5 |
|---|---|
| Molecular Weight | 318.36 |
| Exact Mass | 318.14700 |
| PSA | 57.15000 |
| LogP | 3.21180 |
| Storage condition | -20°C |
| Phenol,4-[2-(3,4-dimethoxyphenyl)ethyl]-2,6-dimethoxy |